Literature DB >> 18626511

Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes.

Shama K Khokhar1, Ramakrishna Kommagani, Madhavi P Kadakia.   

Abstract

p63, known to play a role in development, has more recently also been implicated in cancer progression. Mutations in p63 have been shown to be responsible for several human developmental diseases. Differential splicing of the p63 gene gives rise to p63 isoforms, which can act either as tumor suppressors or as oncogene. In this report, we studied the effects of naturally occurring TAp63gamma mutants on the regulation of p53/p63 and p63 specific target genes. We observed significant differences among p63 mutants to regulate the p53/p63 and p63 specific target genes. Additionally, we observed a differential effect of p63 mutants on wildtype-p63-mediated induction of p53/p63 and p63 specific target genes. We also demonstrated that these mutants differentially regulate the binding of wildtype p63 to the promoter of target genes. Furthermore, the effects of these mutants on cell death and survival were consistent with their ability to regulate the downstream targets when compared to wildtype TAp63gamma. In summary, our data demonstrate that p63 mutants exhibit differential effects on p63 and p53/p63 specific target genes and on the induction of apoptosis, and provide further insight into the function of p63.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626511      PMCID: PMC2760224          DOI: 10.1038/cr.2008.82

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  43 in total

1.  p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.

Authors:  I Katoh; K I Aisaki; S I Kurata; S Ikawa; Y Ikawa
Journal:  Oncogene       Date:  2000-06-22       Impact factor: 9.867

2.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

3.  Regulation of p63 function by Mdm2 and MdmX.

Authors:  M Kadakia; C Slader; S J Berberich
Journal:  DNA Cell Biol       Date:  2001-06       Impact factor: 3.311

4.  The p53 family member genes are involved in the Notch signal pathway.

Authors:  Yasushi Sasaki; Setsuko Ishida; Ichiro Morimoto; Toshiharu Yamashita; Takashi Kojima; Chikashi Kihara; Toshihiro Tanaka; Kohzoh Imai; Yusuke Nakamura; Takashi Tokino
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

5.  Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.

Authors:  J Celli; P Duijf; B C Hamel; M Bamshad; B Kramer; A P Smits; R Newbury-Ecob; R C Hennekam; G Van Buggenhout; A van Haeringen; C G Woods; A J van Essen; R de Waal; G Vriend; D A Haber; A Yang; F McKeon; H G Brunner; H van Bokhoven
Journal:  Cell       Date:  1999-10-15       Impact factor: 41.582

Review 6.  P63 and P73: P53 mimics, menaces and more.

Authors:  A Yang; F McKeon
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

7.  Frequent alteration of p63 expression in human primary bladder carcinomas.

Authors:  B J Park; S J Lee; J I Kim; S J Lee; C H Lee; S G Chang; J H Park; S G Chi
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

Authors:  Makoto Senoo; Yasuko Matsumura; Sonoko Habu
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

9.  p63 expression in normal, hyperplastic and malignant breast tissues.

Authors:  Xiaojuan Wang; Ichiro Mori; Weihua Tang; Misa Nakamura; Yasushi Nakamura; Misako Sato; Takeo Sakurai; Kennichi Kakudo
Journal:  Breast Cancer       Date:  2002       Impact factor: 4.239

10.  Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.

Authors:  Ralf D Kirschner; Katja Sänger; Gerd A Müller; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2008-04-03       Impact factor: 16.971

View more
  6 in total

1.  A noninvasive iRFP713 p53 reporter reveals dynamic p53 activity in response to irradiation and liver regeneration in vivo.

Authors:  Timothy J Humpton; Andreas K Hock; Christos Kiourtis; Marco De Donatis; Frédéric Fercoq; Colin Nixon; Sheila Bryson; Douglas Strathdee; Leo M Carlin; Thomas G Bird; Karen Blyth; Karen H Vousden
Journal:  Sci Signal       Date:  2022-02-08       Impact factor: 8.192

2.  Regulation of VDR by deltaNp63alpha is associated with inhibition of cell invasion.

Authors:  Ramakrishna Kommagani; Mary K Leonard; Stefanie Lewis; Rose-Anne Romano; Satrajit Sinha; Madhavi P Kadakia
Journal:  J Cell Sci       Date:  2009-07-21       Impact factor: 5.285

3.  An allelic series of Trp63 mutations defines TAp63 as a modifier of EEC syndrome.

Authors:  Emma Vernersson Lindahl; Elvin L Garcia; Alea A Mills
Journal:  Am J Med Genet A       Date:  2013-06-14       Impact factor: 2.802

4.  DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa.

Authors:  Jeffrey B Kerr; Karla J Hutt; Ewa M Michalak; Michele Cook; Cassandra J Vandenberg; Seng H Liew; Philippe Bouillet; Alea Mills; Clare L Scott; Jock K Findlay; Andreas Strasser
Journal:  Mol Cell       Date:  2012-09-20       Impact factor: 17.970

5.  Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization.

Authors:  Ramakrishna Kommagani; Maria M Szwarc; Ertug Kovanci; William E Gibbons; Nagireddy Putluri; Suman Maity; Chad J Creighton; Arun Sreekumar; Francesco J DeMayo; John P Lydon; Bert W O'Malley
Journal:  PLoS Genet       Date:  2013-10-24       Impact factor: 5.917

6.  Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.

Authors:  Jar-Yi Ho; Fung-Wei Chang; Fong Shung Huang; Jui-Ming Liu; Yueh-Ping Liu; Shu-Pin Chen; Yung-Liang Liu; Kuan-Chen Cheng; Cheng-Ping Yu; Ren-Jun Hsu
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.